Cadence Pharmaceuticals, a biopharmaceutical company developing drug candidates for use in hospitals, filed for its IPO on Monday. Merrill Lynch, Deutsche Bank, Pacific Growth Equities and JMP Securities are set to manage the deal for the San Diego based company. Terms and timing have yet to be announced.
